Cargando…

Isotoxic High-Dose Stereotactic Body Radiotherapy (iHD-SBRT) Versus Conventional Chemoradiotherapy for Localized Pancreatic Cancer: A Single Cancer Center Evaluation

SIMPLE SUMMARY: Pancreatic ductal adenocarcinoma (PDAC) is an aggressive tumour associated with poor prognosis. The only potentially curative treatment is an oncological surgical resection. To increase the probability of resection, the use of neoadjuvant treatment is explored and can include chemora...

Descripción completa

Detalles Bibliográficos
Autores principales:	Manderlier, Martin, Navez, Julie, Hein, Matthieu, Engelholm, Jean-Luc, Closset, Jean, Bali, Maria Antonietta, Van Gestel, Dirk, Moretti, Luigi, Van Laethem, Jean-Luc, Bouchart, Christelle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9741086/ https://www.ncbi.nlm.nih.gov/pubmed/36497212 http://dx.doi.org/10.3390/cancers14235730

Ejemplares similares

Preoperative treatment with mFOLFIRINOX or Gemcitabine/Nab-paclitaxel +/- isotoxic high-dose stereotactic body Radiation Therapy (iHD-SBRT) for borderline resectable pancreatic adenocarcinoma (the STEREOPAC trial): study protocol for a randomised comparative multicenter phase II trial
por: Bouchart, Christelle, et al.
Publicado: (2023)

Isotoxic high-dose stereotactic body radiotherapy integrated in a total multimodal neoadjuvant strategy for the treatment of localized pancreatic ductal adenocarcinoma
por: Bouchart, Christelle, et al.
Publicado: (2021)

What Should Guide the Performance of Venous Resection During Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma with Venous Contact?
por: Navez, Julie, et al.
Publicado: (2021)

Novel strategies using modern radiotherapy to improve pancreatic cancer outcomes: toward a new standard?
por: Bouchart, Christelle, et al.
Publicado: (2020)

EUS-guided placement of fiducial markers for stereotactic body radiation therapy in pancreatic cancer: feasibility, security and a new quality score
por: Figueiredo, Mariana, et al.
Publicado: (2021)

Combination, Modulation and Interplay of Modern Radiotherapy with the Tumor Microenvironment and Targeted Therapies in Pancreatic Cancer: Which Candidates to Boost Radiotherapy?
por: Benkhaled, Sofian, et al.
Publicado: (2023)

The impact of a multidisciplinary team approach on the management of focal pancreatic lesions: a single tertiary center experience
por: Francisse, Sophie, et al.
Publicado: (2023)

Pancreatic Cancer Meets Human Microbiota: Close Encounters of the Third Kind
por: Arsenijevic, Tatjana, et al.
Publicado: (2021)

Dose Escalation for Pancreas SBRT: Potential and Limitations of using Daily Online Adaptive Radiation Therapy and an Iterative Isotoxicity Automated Planning Approach
por: Rhee, Dong Joo, et al.
Publicado: (2023)

Prognostic impact of glioblastoma stem cell markers OLIG2 and CCND2
por: Bouchart, Christelle, et al.
Publicado: (2019)

SMAD4 Positive Pancreatic Ductal Adenocarcinomas Are Associated with Better Outcomes in Patients Receiving FOLFIRINOX-Based Neoadjuvant Therapy
por: Racu, Marie-Lucie, et al.
Publicado: (2023)

Pancreatic medullary carcinoma developed on a pancreatic intraductal papillary mucinous neoplasm with loss of MSH2 and MSH6 expression: a case report
por: Verocq, Camille, et al.
Publicado: (2021)

Study protocol: a multicentre, prospective, phase II trial of isotoxic hypofractionated concurrent chemoradiotherapy for non-small cell lung cancer
por: Liu, Yue-E, et al.
Publicado: (2020)

Sex Differences in the Pathophysiology, Treatment, and Outcomes in IHD
por: Sanghavi, Monika, et al.
Publicado: (2015)

CVVH versus IHD in patients with multiple organ failure
por: Gašparović, V, et al.
Publicado: (2003)

The current understanding of the immune landscape relative to radiotherapy across tumor types
por: Iliadi, Chrysanthi, et al.
Publicado: (2023)

The recent advances, drawbacks, and the future directions of CMRI in the diagnosis of IHD
por: Fagiry, Moram A., et al.
Publicado: (2021)

Spleen-preserving pancreatectomy with removal of splenic vessels: impact on splenic parenchyma ?
por: Lete, Coralie, et al.
Publicado: (2023)

Treatment of Pancreatic Cancer: What Can We Really Predict Today?
por: Bachet, Jean-Baptiste, et al.
Publicado: (2011)

Epitranscriptomics of Ischemic Heart Disease—The IHD-EPITRAN Study Design and Objectives
por: Sikorski, Vilbert, et al.
Publicado: (2021)

The Plasma B-Type Natriuretic Peptide Levels Are Low in Males with Stable Ischemic Heart Disease (IHD) Compared to Those Observed in Patients with Non-IHD: A Retrospective Study
por: Minai, Kosuke, et al.
Publicado: (2014)

Opioid-free versus opioid-based anesthesia in pancreatic surgery
por: Hublet, Stéphane, et al.
Publicado: (2022)

Correction to: Opioid-free versus opioid-based anesthesia in pancreatic surgery
por: Hublet, Stéphane, et al.
Publicado: (2022)

Impact of COVID-19 Lockdown on Short-Term Results After Laparoscopic Sleeve Gastrectomy
por: El Moussaoui, Imad, et al.
Publicado: (2021)

Generation of a Novel Oncolytic Vaccinia Virus Using the IHD-W Strain
por: Shin, Jaeil, et al.
Publicado: (2021)

Effect of replacement therapy (CRRT) and hemodialysis (IHD) on severe acute renal failure
por: Zhang, Xiangyuan, et al.
Publicado: (2023)

Improved effectiveness of stereotactic radiosurgery in large brain metastases by individualized isotoxic dose prescription: an in silico study
por: Zindler, Jaap D., et al.
Publicado: (2018)

Magnesium profiles in renal replacement therapy (rrt) on icu: citrate CVVH (CICVVH) vs. intermittent haemodialysis (IHD)
por: Billiet, N, et al.
Publicado: (2015)

Aquaporins Involvement in Pancreas Physiology and in Pancreatic Diseases
por: Arsenijevic, Tatjana, et al.
Publicado: (2019)

Prevalence of obstructive airway disease by spirometric indices in non-smoker subjects with IHD and HTN
por: Patil, Virendra C., et al.
Publicado: (2012)

Isotoxic dose escalated radiotherapy for glioblastoma based on diffusion-weighted MRI and tumor control probability—an in-silico study
por: Pang, Yaru, et al.
Publicado: (2023)

Comments: Prevalence of obstructive airway diseases by spirometric indices in non-smoker subjects with IHD and HTN
por: Oquaish, Tazeen, et al.
Publicado: (2013)

Boost modalities in cervical cancer: dosimetric comparison between intracavitary BT vs. intracavitary + interstitial BT vs. SBRT.
por: Benkhaled, Sofian, et al.
Publicado: (2023)

Isotoxic Intensity Modulated Radiation Therapy in Stage III Non-Small Cell Lung Cancer: A Feasibility Study
por: Haslett, Kate, et al.
Publicado: (2021)

Individual isotoxic radiation dose escalation based on V20 and advanced technologies benefits unresectable stage III non-small cell lung cancer patients treated with concurrent chemoradiotherapy: long term follow-up
por: Liu, Ming, et al.
Publicado: (2017)

Decrease in Pancreatic Perfusion of Patients with Type 2 Diabetes Mellitus Detected by Perfusion Computed Tomography
por: Garcia, Tiago Severo, et al.
Publicado: (2021)

Geographic disparities persist despite decline in mortality from IHD in California’s Central Valley 1999–2014
por: Spada, Ralph, et al.
Publicado: (2019)

High-Frequency ECG for Detection of Myocardial Ischemia Associated with Right Coronary Artery Stenosis in IHD Patients
por: Kolosova, K.S., et al.
Publicado: (2020)

Growth Differentiation Factor-15 in Asian IHD Patients: Should We Use to Guide Therapeutic Decision?
por: Jang, Jae-Sik
Publicado: (2023)

A Phase I Study of Concurrent Individualized, Isotoxic Accelerated Radiotherapy and Cisplatin–Vinorelbine–Cetuximab in Patients With Stage III Non–Small-Cell Lung Cancer
por: Dingemans, Anne-Marie C., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_tej5b8681v2og0jnlpqoe0apqe